Johannes Fredebohm
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Analytical and clinical performance validation of HPV-SEQ, a novel NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA.
Journal: Oral oncology
Published: May 02, 2025
Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies.
Journal: Journal of the anus, rectum and colon
Published: September 20, 2023
Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.
Journal: Diagnostics (Basel, Switzerland)
Published: March 01, 2023
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Journal: Oral oncology
Published: November 24, 2022
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.
Journal: Therapeutic advances in medical oncology
Published: May 13, 2022
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
Journal: BMC cancer
Published: November 27, 2021
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 16, 2021
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.
Journal: Journal of clinical medicine
Published: July 18, 2019
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.
Journal: Oncotarget
Published: March 31, 2017
Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS.
Journal: Advances in experimental medicine and biology
Published: October 19, 2016
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
Journal: PloS one
Published: July 01, 2016
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs.
Journal: Molecular oncology
Published: November 26, 2015
Last Updated: 09/26/2026